Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,907.00
Bid: 1,900.00
Ask: 1,902.00
Change: 2.00 (0.10%)
Spread: 2.00 (0.105%)
Open: 1,916.00
High: 1,927.00
Low: 1,898.00
Prev. Close: 1,905.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

Thu, 03rd Mar 2022 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Morgan Stanley cuts Hikma Pharmaceuticals to 'equal-weight' ('overweight') - price target 2,300 (2,800) pence

----------

Deutsche Bank cuts Flutter price target to 13,450 (15674) pence - 'buy'

----------

Berenberg raises Persimmon price target to 3,440 (3,410) pence - 'buy'

----------

UBS cuts Burberry price target to 1,882 (1,928) pence - 'neutral'

----------

Berenberg cuts Polymetal International price target to 500 (1,000) pence - 'buy'

----------

JPMorgan raises Aviva price target to 530 (510) pence - 'overweight'

----------

Barclays cuts abrdn price target to 210 (245) pence - 'equal weight'

----------

Credit Suisse raises Intercontinental Hotels target to 5,200 (4,500) pence - 'neutral'

----------

Credit Suisse cuts Standard Chartered target to 455 (485) pence - 'underperform'

----------

Credit Suisse cuts HSBC price target to 530 (565) pence - 'neutral'

----------

Credit Suisse cuts Royal Mail to 'underperform' ('neutral') - price target 345 (558) pence

----------

FTSE 250

----------

JPMorgan resumes SSP with 'overweight'

----------

JPMorgan cuts Vesuvius price target to 485 (503) pence - 'neutral'

----------

RBC raises Coats Group price target to 100 (95) pence - 'outperform'

----------

Berenberg raises Hiscox price target to 1,075 (1,045) pence - 'hold'

----------

JPMorgan raises Hiscox price target to 850 (830) pence - 'underweight'

----------

JPMorgan raises Centrica price target to 94 (87) pence - 'overweight'

----------

Barclays raises Man Group price target to 240 (235) pence - 'equal weight'

----------

Barclays cuts Ascential price target to (450) pence - 'overweight'

----------

JPMorgan cuts Vistry price target to 1,200 (1,260) pence - 'neutral'

----------

HSBC cuts Spectris to 'hold' ('buy') - target 2,910 (4,325) pence

----------

SMALL CAP

----------

Berenberg raises Petra Diamonds price target to 116 (85) pence - 'hold'

----------

Barclays cuts Just Eat Takeaway price target to 58 (85) EUR - 'overweight'

----------

Investec raises Metro Bank to 'buy' ('hold')

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.